Improved models of tumour cure

International Journal of Radiation Biology

Volumn 70, Issue 5, 1996, Pages 539-553

  Tucker, S L ^a   Taylor, J M G ^b,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; MODEL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; TUMOR REGRESSION;

CLONE CELLS; HUMANS; MODELS, STATISTICAL; NEOPLASMS; POISSON DISTRIBUTION; PROBABILITY; RADIOTHERAPY DOSAGE;

EID: 0029794924     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530096144743     Document Type: Article

References (46)

1. 131I and total body irradiation for treatment of disseminated cancer. International Journal of Radiation Oncology Biology Physics, 32, 713-721.
2. BENTZEN, S. M., 1992, Steepness of the clinical dose-control curve and variation in the in vitro radisosensitivity of head and neck squamous cell carcinoma. International Journal of Radiation Biology, 61, 417-423.
3. BENTZEN, S. M., JOHANSEN, L. V., OVERGAARD, J., and THAMES, H. D., 1991, Clinical radiobiology of squamous cell carcinoma of the oropharynx. International Journal of Radiation Oncology Biology Physics, 20, 1197-1206.
4. BENTZEN, S. M., OVERGAARD, J., THAMES, H. D., OVERGAARD, M., VEJBY HANSEN, P., VON DER MAASE, H., and MEDER, J., 1989, Clinical radiobiology of malignant melanoma. Radiotherapy and Oncology, 16, 169-182.
5. BRAHME, A., 1984. Dosimetric precision requirements in radiation therapy. Acta Radiologica Oncology, 23, 379-391.
6. BRENNER, D. J., 1993, Dose, volume, and tumor-control predictions in radiotherapy. International Journal of Radiation Oncology Biology Physics, 26, 171-179.
7. BRENNER, D. J., HALL, E. J., HUANG, Y., and SACHS, R. K., 1994, Optimizing the time course of brachytherapy and other accelerated radiotherapeutic protocols. International Journal of Radiation Oncology Biology Physics, 29, 893-901.
8. BRISTOW, R. G. and HILL, R. P., 1990, Comparison between in vitro radiosensitivity and in vivo radioresponse in murine tumor cell lines II: in vivo radioresponse following fractionated treatment and in vitro/in vivo correlations. International Journal of Radiation Oncology Biology Physics, 18, 331-345.
9. BROCK, W. A., BAKER, F. L., and PETERS, L. J., 1989, Radiosensitivity of human head and neck squamous cell carcinomas in primary culture and its potential as a predictive assay of tumour radiocurability. International Journal of Radiation Biology, 56, 751-760.
10. DEASY, J., 1996, Poisson formulas for tumor control probability with clonogen proliferation. Radiation Research, 145, 382-384.
11. DUTREIX, J., TUBIANA, M., and DUTREIX, A., 1988, An approach to the interpretation of clinical data on the tumour control probability-dose relationship. Radiotherapy and Oncology, 11, 239-248.
12. FISCHER, J. J. and MOULDER, J. E., 1975, The steepness of the dose-response curve in radiation therapy. Radiology, 117, 179-184.
13. HENDRY, J. H., 1992, Treatment acceleration in radiotherapy: the relative time factors and dose-response slopes for tumours and normal tissues. Radiotherapy and Oncology, 25, 308-312.
14. HENDRY, J. H., ROBERTS, S. A., SLEVIN, N. J., KEANE, T. J., BARTON, M. B., and AGREN-CRONQVIST, A., 1994, Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada. Radiotherapy and Oncology, 31, 14-22.
15. MACIEJEWSKI, B., WITHERS, H. R., TAYLOR, J. M. C., and HLINIAK, A., 1989, Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation. International Journal of Radiation Oncology Biology Physics, 16, 831-843.
16. 10 as a measure of clonogen doubling time in irradiated and unirradiated tumours. International Journal of Radiation Oncology Biology Physics, 21, 1195-1202.
17. MOORE, J. V., HENDRY, J. H. and HUNTER, R. D., 1983, Dose-incidence curves for tumour control and normal tissue injury, in relation to the response of clonogenic cells. Radiotherapy and Oncology, 1, 143-157.
18. MUNRO, T. R. and GILBERT, C. W., 1961, The relation between tumour lethal doses and the radiosensitivity of tumour cells. British Journal of Radiology, 34, 240-251.
19. PETERS, L. J., WITHERS, H. R., THAMES, H. D., and FLETCHER, G. H., 1982, Keynote address - The problem: tumour radioresistance in clinical radiotherapy. International Journal of Radiation Oncology Biology Physics, 8, 101-108.
20. PORTER, E. H., 1980a, The statistics of dose/cure relationships for irradiated tumours. Part I. British Journal of Radiology, 53, 210-227.
21. PORTER, E. H., 1980b, The statistics of dose/cure relationships for irradiated tumours. Part II. British Journal of Radiology, 53, 336-345.
22. ROBERTS, S. A. and HENDRY, J. H., 1993, The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data. Radiotherapy and Oncology, 29, 69-74.
23. ROBERTS, S. A., HENDRY, J. H., BREWSTER, A. E., and SLEVIN, N. J., 1994, The influence of radiotherapy treatment time on the control of laryngeal cancer: a direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor. British Journal of Radiology, 67, 790-794.
24. ROBERTSON, A. G., ROBERTSON, C., BOYLE, P., SYMONDS, R. P., and WHELDON, T. E., 1993, The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx. European Journal of Cancer, 29A, 501-510.
25. SMITH, J. A. and MARTIN, L., 1973, Do cells cycle? Proceedings of the National Academy of Sciences USA, 70, 1263-1267.
26. 3 laryngeal cancer using radiotherapy. Radiotherapy and Oncology, 24, 215-220.
27. STUSCHKE, M., BUDACH, V., BUDACH, W., FELDMAN, H.-J., and SACK, H., 1992a, Radioresponsiveness, sublethal damage repair and stem cell rate in spheroids from three human tumor lines: comparison with xenograft data. International Journal of Radiation Oncology Biology Physics, 24, 119-126.
28. STUSCHKE, M., BUDACH, V., KALFF, R. L., SACK, H., BAMBERG., M., REINHARDT, V., and FELDMAN, H. J., 1993a, Spheroid control of malignant glioma cell lines after fractionated irradiation: relation to surviving fractions at 2Gy and colony forming efficiencies in a soft agar clonogenic assay. Radiotherapy and Oncology, 27, 245-251.
29. STUSCHKE, M., BUDACH, V., KLAES, W., and SACK, H., 1992b, Radiosensitivity, repair capacity, and stem cell fraction in human soft tissue tumors: an in vitro study using multicellular spheroids and the colony assay. International Journal of Radiation Oncology Biology Physics, 23, 69-80.
30. STUSCHKE, M., BUDACH, V., and SACK, H., 1993b, Radioresponsiveness of human glioma, sarcoma, and breast cancer spheroids depends on tumor differentiation. International Journal of Radiation Oncology Biology Physics, 27, 627-636.
31. STUSCHKE, M., BUDACH, V., STUEBEN, G., STREFFER, C., and SACK, H., 1995, Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system. International Journal of Radiation Oncology Biology Physics, 32, 395-408.
32. SUTT, H., SKATES, S., TAGHIAN, A., OKUNIEFF, P., and EFIRD, J. T., 1992, Clinical implications of heterogeneity of tumor response to radiation therapy. Radiotherapy and Oncology, 25, 251-260.
33. TAYLOR, J. M. G., TUCKER, S. L., and THAMES, H. D., 1993, The probability of tumor cure: Response to comments by Dr Yakovlev. Radiation Research, 134, 121-122.
34. TEPPER, J., 1981, Clonogenic potential of human tumors: a hypothesis. Acta Radiologica Oncology, 20, 283-288.
35. THAMES, H. D., ROZELL, M. E., TUCKER, S. L., ANG, K. K., FISHER, D. R., and TRAVIS, E. L., 1986. Direct analysis of quantal radiation response data, International Journal of Radiation Biology, 49, 999-1009.
36. THAMES, H. D., SCHULTHEISS, T. E., HENDRY, J. H., TUCKER, S. L., DUBRAY, B. M, and BROCK, W. A., 1991, Can modest escalations of dose be detected as increased tumor control? International Journal of Radiation Oncology Biology Physics, 22, 241-240.
37. TUCKER, S. L., 1989, Expected changes in local tumor control rates resulting from the selective use of accelerated fractionation. International Journal of Radiation Biology, 56, 739-743
38. TUCKER, S. L., and CHAN, K.-S., 1990. The selection of patients for accelerated radiotherapy on the basis of tumor kinetics and intrinsic radiosensitivity. Radiotherapy and Oncology, 18, 197-211.
39. TUCKER, S. L., and THAMES, H. D., 1989, The effect of patient-to-patient variability on the accuracy of predictive assays of tumor response to radiotherapy: a theoretical evaluation. International Journal of Radiation Oncology Biology Physics, 17, 145-157.
40. TUCKER, S. L., Thames, H. D., and Taylor, J. M. G., 1990, How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics? Radiation Research, 124, 273-282.
41. YAKOVLEV, A. YU., 1993, Comments on the distribution of clonogens in irradiated tumors. Radiation Research. 134, 117-120.
42. YAKOVLEV, A. YU, and YANEV, N. M., 1989. Lecture Notes in Biomathematics: Transient Processes in Cell Proliferation Kinetics (New York: Springer-Verlag).
43. WANG, C. C., 1985, Improved local control for advanced oropharyngeal carcinoma following twice daily radiation therapy. American Journal of Clinical Oncology: Cancer Clinical Trials, 512-516.
44. WITHERS, H. R., PETERS, L. J., and TAYLOR, J. M. G., 1995, Dose-response relationship for radiation therapy of subclinical disease. International Journal of Radiation Oncology Biology Physics, 31, 353-359.
45. WITHERS, H. R., TAYLOR, J. M. G., and MACIEJEWSKI, B., 1988, The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncologica, 27, 131-146.
46. ZAGARS, G. K., SCHULTHEISS, T. F,., and PETERS, L. J., 1987, Inter-tumor heterogeneity and radiation dose-control curves. Radiotherapy and Oncology. 8, 353-362.